Palamedrix

About:

Palamedrix leverages DNA nanotechnology for advancements in life science and medicine.

Website: https://www.palamedrix.com/

Top Investors: Casdin Capital, FoundersX Ventures

Description:

Palamedrix is a developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company utilizes DNA nanotechnology to procure solutions for biomedical applications by providing comprehensive data. Palamedrix was established in 2017 by Shane Bowen in San Diego, California.

Total Funding Amount:

$6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2020-01-01

Founders:

Ashwin Gopinath, Shane Bowen

Number of Employees:

1-10

Last Funding Date:

2021-03-01

IPO Status:

Private

Industries: